Laryngeal disorder and drugs of ingredients of bromocriptine mesylate - a phase IV clinical study of FDA data


Laryngeal disorder is found among people who take drugs with ingredients of bromocriptine mesylate, especially for people who are female, 60+ old . This phase IV clinical study is created by eHealthMe based on reports of 4,429 people who have side effects when taking drugs with ingredients of bromocriptine mesylate from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Bromocriptine mesylate, Cycloset, Parlodel.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 24, 2023

4,429 people reported to have side effects when taking drugs with ingredients of bromocriptine mesylate.
Among them, 7 people (0.16%) have Laryngeal disorder

What is Laryngeal disorder?

Laryngeal disorder (disease of larynx related to voice) is found to be associated with 492 drugs and 253 conditions by eHealthMe.

Number of reports submitted per year:

Could drugs with ingredients of bromocriptine mesylate cause Laryngeal disorder?

Gender of people who have Laryngeal disorder when taking drugs with ingredients of bromocriptine mesylate *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Laryngeal disorder when taking drugs with ingredients of bromocriptine mesylate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 14.29 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 85.71 %

Conditions people have *:

  1. Parkinson's Disease: 6 people, 85.71%
  2. Prolactin-Producing Pituitary Tumor: 1 person, 14.29%
  3. Osteoporosis (bones weak and more likely to break): 1 person, 14.29%
  4. Gastrointestinal Hypomotility (less activity of the intestinal tract): 1 person, 14.29%
  5. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 14.29%
  6. Breast Cancer: 1 person, 14.29%
  7. Bone Pain: 1 person, 14.29%

Other drugs people take *:

  1. Symmetrel: 6 people, 85.71%
  2. Selegiline Hydrochloride: 4 people, 57.14%
  3. Omega 3: 2 people, 28.57%
  4. Vitamin D: 1 person, 14.29%
  5. Gravol: 1 person, 14.29%
  6. Arimidex: 1 person, 14.29%
  7. Asa: 1 person, 14.29%
  8. Atrovent: 1 person, 14.29%
  9. Bisacodyl: 1 person, 14.29%
  10. Calcium: 1 person, 14.29%

Other side effects people have besides Laryngeal disorder *:

  1. Breathing Difficulty: 7 people, 100.00%
  2. Movement - Uncontrolled Or Slow: 6 people, 85.71%
  3. Breathing Sounds - Abnormal (Stridor): 6 people, 85.71%
  4. Skin Discoloration - Bluish (bluish colour of skin): 6 people, 85.71%
  5. Weakness: 1 person, 14.29%
  6. Hot Flush (sudden feelings of heat): 1 person, 14.29%
  7. Lung Disorder (lung disease): 1 person, 14.29%
  8. Lower Respiratory Tract Infection: 1 person, 14.29%
  9. Leukoplakia Oral (white and gray patches inside the mouth): 1 person, 14.29%
  10. Laryngitis (inflammation of the larynx): 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drugs with ingredients of bromocriptine mesylate, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on bromocriptine mesylate. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: